Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001437749-25-032197
Filing Date
2025-10-29
Accepted
2025-10-29 16:24:56
Documents
62
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A bcda20250630_10qa.htm   iXBRL 10-Q/A 794558
2 EXHIBIT 31.1 ex_877399.htm EX-31.1 10854
3 EXHIBIT 31.2 ex_877400.htm EX-31.2 10624
4 EXHIBIT 32.1 ex_877401.htm EX-32.1 4230
5 EXHIBIT 32.2 ex_877402.htm EX-32.2 4152
  Complete submission text file 0001437749-25-032197.txt   4214087

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bcda-20250630.xsd EX-101.SCH 43582
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20250630_def.xml EX-101.DEF 276641
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20250630_lab.xml EX-101.LAB 242237
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20250630_pre.xml EX-101.PRE 306070
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcda-20250630_cal.xml EX-101.CAL 26875
65 EXTRACTED XBRL INSTANCE DOCUMENT bcda20250630_10qa_htm.xml XML 597973
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-38999 | Film No.: 251430353
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)